12:00 AM
 | 
Jan 14, 2013
 |  BC Week In Review  |  Company News  |  Deals

Pepscan Therapeutics deal

Pepscan will discover antibodies against multiple targets with an undisclosed U.S.-based antibody discovery company. Pepscan will use its Chemical Linkage of Peptides...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >